Tumour necrosis factor (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-Rp55 and sIL-6R) serum levels in systemic lupus erythematodes
1996

Cytokine Levels in Systemic Lupus Erythematosus

Sample size: 71 publication Evidence: moderate

Author Information

Author(s): E. Robak, A. Sysa-Jdrzejowska, T. Robak, H. Stpiefi, A. Woniacka, E. Waszczykowska

Primary Institution: Medical University of Lodz, Poland

Hypothesis

There is an association between serum concentrations of TNF-alpha, IL-6, and their soluble receptors in patients with systemic lupus erythematosus (SLE).

Conclusion

Increased serum levels of TNF-alpha, sTNF-Rp55, and IL-6 may serve as useful markers for SLE activity.

Supporting Evidence

  • Serum levels of TNF-alpha were significantly higher in SLE patients compared to healthy controls.
  • Positive correlations were found between TNF-alpha and IL-6 concentrations and disease activity.
  • IL-6 levels were elevated in active SLE patients compared to controls.

Takeaway

This study found that people with a disease called lupus have higher levels of certain proteins in their blood, which can help doctors understand how active the disease is.

Methodology

The study measured serum concentrations of TNF-alpha, IL-6, and their soluble receptors using ELISA in patients with SLE and healthy controls.

Limitations

The study did not include a diverse demographic and focused only on specific cytokines.

Participant Demographics

55 patients with SLE (53 women, 2 men) aged 20-66 years, and 16 healthy controls.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication